av/aptevo-therapeutics--big.svg

NASDAQ:APVO

Aptevo Therapeutics Inc.

  • Stock

USD

Last Close

0.80

17/05 20:00

Market Cap

3.40M

Beta: 5.32

Volume Today

160.54K

Avg: 60.96K

PE Ratio

0.07

PFCF: −0.27

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
170K
-
45.63M
26,741.76%
33.60M
26.36%
36.43M
8.43%
14.66M
59.77%
23.07M
57.37%
32.42M
40.56%
4.31M
86.71%
12.29M
185.26%
3.11M
74.67%
cost of revenue
16.25M
-
16.93M
4.18%
24.18M
42.81%
5.01M
79.28%
11.21M
123.83%
19.93M
77.70%
18.99M
-
901K
95.26%
567K
37.07%
gross profit
170K
-
29.38M
17,180.59%
16.67M
43.26%
12.25M
26.49%
9.65M
21.25%
11.85M
22.85%
12.50M
5.43%
4.31M
65.52%
-6.70M
255.53%
2.21M
133.02%
-567K
125.62%
selling and marketing expenses
general and administrative expenses
16.20M
-
13.95M
13.88%
14.70M
5.35%
13.87M
5.61%
11.77M
15.15%
selling general and administrative expenses
15.45M
-
34.28M
121.86%
43.04M
25.56%
38.67M
10.17%
34.58M
10.58%
28.13M
18.63%
16.20M
42.42%
13.95M
13.88%
14.70M
5.35%
13.87M
5.61%
11.77M
15.15%
research and development expenses
38.07M
-
46.59M
22.36%
34.73M
25.46%
29.52M
15.00%
29.02M
1.68%
35.38M
21.93%
24.76M
30.02%
17.85M
27.91%
18.99M
6.40%
17.88M
5.85%
16.54M
7.50%
other expenses
15.45M
-
34.28M
121.86%
43.04M
25.56%
38.67M
10.17%
34.58M
10.58%
-2.02M
105.85%
-2.10M
3.85%
-1.32M
36.96%
-8.01M
504.38%
-1.53M
80.93%
cost and expenses
53.52M
-
97.12M
81.45%
94.70M
2.49%
92.37M
2.47%
68.61M
25.72%
74.73M
8.93%
40.96M
45.19%
31.80M
22.36%
33.69M
5.94%
31.75M
5.75%
28.88M
9.06%
operating expenses
53.52M
-
80.87M
51.09%
77.77M
3.83%
68.18M
12.32%
63.60M
6.73%
63.52M
0.12%
40.96M
35.51%
31.80M
22.36%
33.69M
5.94%
31.75M
5.75%
28.31M
10.85%
interest expense
-35.66M
-
ebitda
-52.71M
-
-49.25M
6.56%
-57.96M
17.68%
19.25M
133.22%
-48.88M
353.87%
-49.27M
0.81%
-38.73M
21.41%
-25.39M
34.44%
-21.40M
15.71%
-64.92M
203.37%
-28.31M
56.39%
operating income
-53.35M
-
-51.49M
3.49%
-61.10M
18.66%
-126.94M
107.77%
-53.95M
57.50%
-51.66M
4.23%
-40.96M
20.72%
-27.49M
32.88%
-21.40M
22.16%
-28.64M
33.84%
-28.88M
0.83%
depreciation and amortization
666K
-
2.02M
203.45%
2.91M
43.84%
3.36M
15.65%
3.13M
6.99%
2.39M
23.57%
2.23M
6.49%
2.10M
5.86%
1.14M
45.63%
-36.28M
3,271.42%
567K
101.56%
total other income expenses net
18K
-
-222K
1,333.33%
-237K
6.76%
-71.82M
30,205.06%
-1.94M
97.29%
-2.02M
4.12%
-2.10M
3.85%
-3.43M
63.13%
-8.01M
133.54%
35.66M
545.24%
10.23M
71.31%
income before tax
-53.34M
-
-51.71M
3.04%
-61.34M
18.61%
-127.75M
108.28%
-55.89M
56.25%
-53.69M
3.94%
-43.06M
19.79%
-30.92M
28.19%
-29.41M
4.90%
7.01M
123.85%
-18.65M
365.90%
income tax expense
-18K
-
-599K
3,227.78%
-2.02M
237.23%
-15.34M
659.41%
-23.30M
51.90%
-2.02M
91.31%
-2.62M
29.25%
-12.47M
376.87%
-2.10M
83.21%
-35.66M
1,601.91%
-1.24M
96.53%
net income
-53.34M
-
-51.12M
4.17%
-59.32M
16.05%
-112.42M
89.52%
6.97M
106.20%
-53.69M
869.96%
-40.45M
24.66%
-18.45M
54.39%
-27.31M
48.05%
42.67M
256.22%
-17.41M
140.80%
weighted average shs out
1.41M
-
1.41M
0%
1.41M
0%
1.45M
2.37%
1.52M
5.42%
1.61M
5.46%
4.74K
99.71%
77.07K
1,527.43%
106.54K
38.25%
115.92K
8.80%
278.06K
139.88%
weighted average shs out dil
1.41M
-
1.41M
0%
1.41M
0%
1.45M
2.37%
1.52M
5.42%
1.61M
5.46%
4.74K
99.71%
77.07K
1,527.43%
106.54K
38.25%
115.97K
8.85%
278.06K
139.76%
eps
-37.77
-
-36.19
4.18%
-42
16.05%
-77.76
85.14%
4.62
105.94%
-33.41
823.16%
-8.54K
25,465.82%
-239.38
97.20%
-256.35
7.09%
368.10
243.59%
-62.62
117.01%
epsdiluted
-37.77
-
-36.19
4.18%
-42
16.05%
-77.76
85.14%
4.62
105.94%
-33.41
823.16%
-8.54K
25,465.82%
-239.38
97.20%
-256.35
7.09%
367.92
243.52%
-62.62
117.02%

All numbers in USD (except ratios and percentages)